Log In
BCIQ
Print this Print this
 

SB-728mR-HSPC

  Manage Alerts
Collapse Summary General Information
Company Sangamo BioSciences Inc.
DescriptionHematopoietic stem and progenitor cells modified at the CC chemokine receptor 5 (CCR5) gene by CCR5-specific zinc finger DNA binding protein nucleases (ZFN)
Molecular Target CC chemokine receptor 5 (CCR5) (CD195)
Mechanism of Action 
Therapeutic ModalityCell therapy: Stem cell
Latest Stage of DevelopmentPhase I/II
Standard IndicationHIV / AIDS
Indication DetailsTreat HIV infection
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today